SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-12-332282
Filing Date
2012-08-02
Accepted
2012-08-02 17:31:29
Documents
6
Period of Report
2012-08-02

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d383481dprem14a.htm PREM14A 1561620
2 GRAPHIC g383481g43s80.jpg GRAPHIC 15124
3 GRAPHIC g383481g84t56.jpg GRAPHIC 7820
4 GRAPHIC g383481pg1.jpg GRAPHIC 142525
5 GRAPHIC g383481pg2.jpg GRAPHIC 164139
6 GRAPHIC g383481pg3.jpg GRAPHIC 185528
  Complete submission text file 0001193125-12-332282.txt   2273199
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-10827 | Film No.: 121004574
SIC: 2834 Pharmaceutical Preparations